This clinical trial is for people who have moderate to severe hair loss from Alopecia Areata. Basic criteria are listed below. Click to sign up or request more info.
OFFICIAL TITLE:
A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adult Alopecia Areata Participants with 50% or Greater Scalp Hair Loss
Volunteers needed for a clinical trial lasting up to 29 weeks long with 11 office visits for an Investigational product. Up to $1,825.00 stipend available. Additional financial assistance available for subjects travelling over 62.1 miles for each office visit.
To Qualify, you must meet the following INCLUSION CRITERIA:
1.) Greater than 18 years of age. Less than 65 years of age.
2.) Have MODERATE to SEVERE Alopecia Areata.
3.) Minimum SALT Score of 50 (to be determined at Screening Visit).
To Qualify, you must NOT meet the following EXCLUSION CRITERIA:
1.) Known Hepatitis B, C, or HIV.
2.) Pregnant or lactating
3.) Active drug or alcohol dependence
ClinicalTrials.gov Identifier: NCT06060977
https://clinicaltrials.gov/study/NCT06060977?cond=alopecia&term=inmagene&checkSpell=false&rank=1
We love our patients, so feel free to visit during normal business hours.
Mon | 08:00 am – 05:00 pm | |
Tue | 08:00 am – 05:00 pm | |
Wed | 08:00 am – 05:00 pm | |
Thu | 08:00 am – 05:00 pm | |
Fri | 09:00 am – 03:00 pm | |
Sat | Closed | |
Sun | Closed |
Copyright © 2024 Principle Research Solutions,llc - All Rights Reserved.
Your One-Stop Research SOLUTION
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.